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A b s t r a c t  
Herbal medicines has been reported to play an important role in the discovery of new drugs for the 
treatment of human diseases, including cancer [1]. Many herbal remedies have shown to play 
anticancer role through multiple mechanisms (Ikezoe et al. 2003; Cheng et al. 2003; Hong-Fen et al. 
2001, Hsieh et al. 2002; Wartenberg et al. 2003). Our present work is an attempt to screen some 
essential components from the water weed Pistia stratiotes and to study its potentiality against the side 
effects induced by radiotherapy and chemotherapy 






Cancer is the leading cause of death worldwide. Different treatment 
modalities are on their way to treat cancer. The most common 
treatment modalities include: Chemotherapy and Radiotherapy. 
Many of the studies has shown severe damage caused by 
exposure to radiation and chemotherapy. 
Being the most common treatment, radiotherapy and 
chemotherapy itself causes many alterations in the cellular and the 
genetic level. Many herbal crude drugs including Ocimum sanctum, 
Basil etc (P U Devi et. al) has shown a good response to reduce 
the cytotoxicity caused by radiation. The herbal crude extract of 
Pistia stratiotes is used in this work to study its potentiality to 
reduce toxicity caused due to radiation and chemotherapy drugs. 
The crude extract  derived from the water weed; Pistia stratiotes 
has shown to contain Alkaloids and steroids which may play 
an important role in reducing the toxicity induced by radiotherapy 
and chemotherapy. In this work we have shown that the crude 
extract of Pistia stratiotes are rich in anti-oxidants which are the 
potential candidate to reduce the toxicity induced by both radiation 
and chemotherapy in Swiss albino mice model. 
Methods 
Collection of plant materials 
 
Pistia stratiotes, the total plant with its leaves and roots were 
collected from the upper and the lower lake of Bhopal. Weight of 
the plant sample (Pistia stratiotes) collected was taken immediately 
just after the sample collection. 
Extraction 
Powder of leaves of Pistia stratiotes (2-3 weeks after shade drying) 
was weighed & loaded in a separating funnel with 50% methanol. 
The concentrated crude extract was formed as a result of 
evaporation of the solvent (50 % methanol) in a water bath at 45�C, 
thereby forming a brown colored marc, with fine crystals. This 
colected crude extract crystals was then used as 50% methanolic 
extract (50 % ME) for the experiment. 
Phytochemical screening 
The methanolic extract of the crude drug (Pistia stratiotes) was 
subjected to systematic phytochemical screening to assess the 
presence of diferent phytoconstituents such as alkaloids, 
glycosides, proteins, amino acids, sterols, carbohydrates 
compounds, acidic compounds, resins etc [61]. 
Thin layer chromatography 
Thin layer chromatography (TLC) was performed using petroleum 
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the extracts were used after dissolving them in their respective 
solvents to prepare sample solutions. 
Column chromatography 
The crude drug 50 % methanolic extract (Pistia stratiotes) was 
used for column chromatography. Silica gel (100-200 mesh) was 
used as a stationary phase and successive solvent systems were 
used ranging from non-polar to polar solvents. The rate of elution 
was fixed at 10 drops per minute. Diferent fractions of the diferent 
solvents used, were colected and used for λ max calculation using 
UV-spectrophotometer (data not shown). 
Experimental Animals 
The Swiss albino mice of the mean weight of 31gm and 6-7 weeks 
old were obtained from the animal house, Jawaharlal Nehru 
Cancer Hospital & Research center, Bhopal. The use of animal 
was as per CPCSEA norms. Approval for experimental work was 
as per ethical commitee of Jawaharlal Nehru Cancer Hospital and 
Research Centre, Bhopal (M.P.). 
Preparation and Administration of Test 
Drug (50% ME of Pistia stratiotes) 
solution 
The amount of the test drug (50% ME) to be administered was 
calculated depending on the body weight of the animal and the 
design of experiment. The crude drug was administered oraly to 
each animal by using a cannula. 
Experimental Design 
Animals were divided into six groups of four animals each, for both 
Radiotherapy as wel as chemotherapy groups. The groups were 
treated as folows: 
Induction of Radiation on experimental 
animals 
Unanesthetized mice were restrained in ventilated Perspex box 
and the groups including : B, C, E and F were given 9 Gy as 
discussed in the protocol. The whole body dose was given at the 
rate of 150 cGy/min by Co-60 Tele-therapy unit (Theratron 780 C, 
Co unit manufactured by M/S Theratronics Ltd, Canada), at a 
distance of 80 cm from the source, atJawaharlal Nehru cancer 
hospital and Research center, as previously described by M. R. 
Adhvaryu et al. (2008). The commercial radio-protective drug 
(Antioxidant: Antoxid) dose was given to the animals belonging to 
group B, along with the γ –radiation (9 Gy). The stock solution was 
prepared in water for injection and the dose was given as per the 
 
body weight (100 mg/kg body weight). 
Induction of Chemotherapeutic drugs on 
experimental animals 
A freshly prepared solution of Cyclophosphamide (50 mg/kg body 
weight as previously discussed, Ralf Paus, Bori Handjiski et. 
al, 1994) in DDW was injected intra-peritoneal to the mice 
belonging to groups (Group Q, R, T, U). The stock solution of Multi-
vitamin Infusion (MVI) was prepared in water for injection and the 
dose was given to group Q as per the body weight (100 mg/kg 
body weight). 
Histopathological Studies 
Major organs (including Intestine, Liver, kidney and spleen) of both 
the group of animals were flushed with normal saline & fat tissues 
were removed and fixed in 10% formalin solution for histo-
pathological evaluation to assess chronic toxicity of the crude 
herbal extract on these organs and also the efect of radiotherapy 
and chemotherapy on these biological specimens. The histo-
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pathological section was done by Pal Diagnostic Centre, Guru 
Khalsa Hospital, Bhopal (M.P). 
Chromosomal, Apoptosis and 
Micronucleus Studies 
Weight of the mice was recorded. 0.1 ml/gm body weight colchicine 
(0.025%) was injected into peritoneal cavity of the mice. After two 
hrs of injection, the mice were kiled by cervical dislocation. Bone 
marow from the femur bone was used for the chromosomal, 
Apoptosis and Micronucleus studies as described M. R. Adhvaryu*, 
S. P. Srivastav et. al, 2008. It was proposed independently by 
Schmid [68] and Heddle [69] that an alternative and simpler 
approach to assess chromosome damage in vivo was to measure 
micronuclei (MNi), also known as Howel–Joly bodies, in dividing 
cel populations such as the bone-marow. Number of cels having 
abberations per 50 normal cels were counted and Data was 
analyzed by ANOVA. 
Results and Discussion 
Phytochemistry 
Phytochemical analysis of the 50 % crude Methanolic extract of the 
leaves of Pistia stratiotes revealed high suficient amount of 
deoxysugars were found during the phytochemical screening 
(Table No. 1). 
 






The crude drug extract (50% methanolic extract) of Pistia stratiotes 
was seen to show best resolution in Chloroform: Methanol (9:1) 
(Data not shown). Diferent fractions of each of the solvents used in 
column chromatography were colected and λ-max was recorded 
using UV double beam spectrophoto-meter (Data not shown). 
Histopathological studies 
Diferent histopathological studies of organs revealed the damaged 
Crypt & Vili to be prominent in both the groups, whereas there was 
much less toxicity found in the test drug group of both conc. 100 & 
500 mg/kg body weight, as shown in the Fig.1. 
In vivo study 
Six groups each for both Radiotherapy and chemotherapy were 
used for the In vivo study, so as to evaluate the ability of crude 
extract of Pistia stratiotes against toxicity induced by chemo-
therapy and radiotherapy. 
Anthropometry (body & spleen weight 
profile) 
 Table 2 and 4 shows no any significant diference in the body 
weight of the two groups, whereas Table 3 shows a very significant 
decrease in the spleen weight within the radiation treated groups. 
Table 2: Body Weight Diference in mice before and after γ -
Radiation exposure (9 Gy) 
 
 
* L : Left ear mark, R : Right ear mark, LR : Left & Right ear mark, 
NM : No mark. 
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Group A : Normal control (No any treatment of any crude drug 
or radiation), Group B : Standard Radioprotective Drug 
(Antioxidants; Antoxid + γ-Radiation; 9 Gy), Group C : Radiation 
control (only γ-Radiation : 9 Gy), Group D : Test drug control (only 
50 % ME of Pistia stratiotes, conc. 500 mg/kg B.wt), Group E : Test 
Drug (conc. 100mg/kg B.wt) + γ- Radiation (9 Gy), Group F : Test 
Drug (conc. 500 mg/kg B.wt) + γ-Radiation (9 Gy) 
 
Table 3: Spleen weight diference in mice after 
γ-Radiation exposure (9 gy) 
 
 
* L : Left ear mark, R : Right ear mark, LR : Left & Right ear 
mark, NM : No mark. 
Chemotherapy Group 
P : Normal control (No any treatment of any crude drug or 
cyclophosphamide), Q : Standard Chemopreventive drug (MVI)+ 
cyclo- phosphamide, R : Chemotherapy control (only 
cyclophosphamide), S : Test Drug control (50 % ME Pistia 
stratiotes), T : 100 mg Test Drug + cyclophosphamide, U : 500 mg 
Test Drug + cyclophosphamide. 
Histopathological studies; Tissue 
protection (Crypt & vili count) 
Both the Radiation as wel as the chemotherapy groups show 
much diference in the crypt and vili counts in the crude drug 
treated as wel as controls as shown in Table: 7, 8 and Graph: 
1,2,3 and 4, showing the protective nature of the crude drug (50 % 





Fig 1: Histopathological sections of Intestine belonging to Radiation 
group 
(A) Normal control (No any treatment of crude drug or γ -
Radiation) showing intact crypt & vili, (B) Standard 
Radioprotective Drug control (γ – Radiation: 9 Gy + Antoxid) 
showing radioprotective nature of commercialy available drug, (C) 
Radiation control (only γ –Radiation: 9 Gy) showing damaged crypt 
& vili counts compared to normal, (D) Crude Drug control (only 
50% ME of Pistia) showing normal crypt & vili counts, (E) 100 
mg Crude Drug + γ –Radiation: 9 Gy showing protective nature, 
(F) 500 mg Crude Drug + γ –Radiation: 9 Gy showing beter 
protective nature than 100 mg, compared to radiation control. * NC: 
Normal crypt, CL: Crypt of Lieberkuhn, GC: Goblet cels, NV: 
Normal vili, DV: Damaged vili, IV: Inflamated vili, IC: Inflamated 
crypt 
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Graph 1, 2: Comparison between the Normal & Inflamated crypt & 
vili counts in Radiation group 
 
Fig 2: Histopathological sections of Intestine belonging to 
Chemotherapy group (P) Normal control (No any treatment of 
crude drug or cyclophosphamide) showing intact crypt & vili, (Q) 
Standard Chemopreventive Drug control (cyclophosphamide + 
MVI) showingchemopreventive nature, (R) Chemotherapy control 
(only cyclophosphamide) showing damaged crypt & vili counts 
compared to normal, (S) Crude Drugcontrol (only 50% ME of 
Pistia) showing normal crypt & vili counts, (T) 100 mg Crude Drug 
+cyclophosphamide, showing protective nature, (U) 500 mg Crude 
Drug + cyclophosphamide, showing beter protective nature than 
100 mg, compared to chemotherapy control. 
 
Graph 3, 4: Comparison between the Normal & Inflamated crypt & 
vili counts in chemotherapy group 
Genotoxicity study (Chromosomal 
Apoptosis and Micronucleus) 
 The micronucleus and the apoptotic cel counts in group E and F 
does not vary significantly, but as compared to the group B 
(standard Radioprotective drug: Antoxid + γ-Radiation; 9 Gy), 
group F with the crude drug concentration 500 mg/kg b.wtshows 
nearly equal protective nature (Table: 9, Fig: 5). In the 
chemotherapy group, group U with the crude drug concentration 
500 mg/kg b.wt shows nearly equivalent protective nature when 
compared with the group Q (cyclo- phosphamide + MVI) (Table: 
10, Fig: 6). 
 
 
Graph 5, 6: Showing number of Normal versus micronucleus & 
apoptotic cels in Radiation and Chemotherapy groups types of 
aberations have been seen in the Radiation group treated with γ-
Radiation (9Gy). The toxicity induced by the radiation is most 
prominent in the radiation control group (C). The crude drug extract 
(50 % ME Pistia stratiotes) 
 
given in two diferent concentrations (ie. 100 mg and 500 mg/kg 
b.wt), in the groups E and F respectively, shows a good protective 
ability. The group F with 500 mg/kg B.wt shows a significant 
decrease in the toxicity levels as compared to the radiation control 
group C (Table 11, Graph  
Fig 3: Chromosomal aberations due to γ –Radiation (9 Gy) 
in Radiation group 
(a) Normal Metaphase, (b) & (c) Aberant Metaphase, 
(d) Micronucleus. * frg: Fragment, TD: Terminal Deletion, DC: 
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Dicentric, DM: Double Minute, MN: Micronucleus 
 
Graph 7: Comparative study of diferent aberations in al groups 
caused due to iradiation Radiation Group: A: Normal control, B: 
Standard Radio-protective (γ -Radiation 9 Gy + antoxid), C: 
Radiation control (only γ- Radiation: 9 Gy), D: Crude Drug control 
(only 50 % ME of Pistia), E: 100 mg Crude Drug + 9 Gy, F: 500 mg 
Crude Drug + 9 Gy * TM: Total Metaphase, FBD: Fragment Break 
Deletion, NM: Normal Metaphase, PP: Polyploidy, AM: Aberant 
Metaphase, BB: Bubbling, DC: Dicentric, ER: Endo-reduplication, 
MIN: Minute, OT: Others, PCD: Premature Centromeric Division, 
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